BioSpace News Archive

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company , today announced that through its commercial licensing agreement with the University of Maryland, Baltimore (UMB) the U.S. Patent and Trademar

The Manhattan-based fertility center Reproductive Medicine Associates of New York (RMA of New York) presented 31 scientific abstracts at the 76th annual meeting of the American Society for Reproductive Medicine (ASRM)

Nanoform Finland Plc (“Nanoform”), an innovative nanoparticle medicine enabling company will, in the fourth quarter of 2020, start the first ever human trial of a drug candidate nanoformed using Nanoform’s proprietary CESS® technology.

Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, will report fourth quarter and full year 2020 financial results Friday, November 13, 2020. Jack Kenny, Chief Executive Officer, and Bryan Baldasare, Executive Vice President and Chief Financial Officer, will host a conference call beginning at 10:00 a.m. Eastern Time to discuss the results and answer questions. To participate in t

Immunicom, Inc. Founder and CEO, Amir Jafri, has been named one of the top eight healthcare leaders by CEO Today Magazine in its 2020 Healthcare Awards.

ColdQuanta, the quantum atomics company, today announced “Albert,” its quantum matter system on the cloud. With Albert, users can explore fundamental quantum phenomena such as tunneling and superposition by generating, manipulating, and experimenting with ultracold matter.

FineHeart, SA, a preclinical-stage medical device company developing an Implantable Cardiac Output Management System (ICOMS) to address the unmet need of patients suffering from severe heart failure, today announced the successful completion of a 30-day preclinical study.

Cytocom, Inc. (Cytocom), a leading biopharmaceutical company in the area of immune-modulation, and Cleveland BioLabs, Inc., an innovative biopharmaceutical company developing novel approaches to activate the immune system, today announced that they have entered into a definitive merger agreement to combine their businesses in an all-stock transaction. Cytocom shareholders will have a majority position in the newly combined entity, which the

- Company supports patient safety; innovating topical anesthetic gel to produce the first widely available sterile option from a 503B Outsourcing Facility - hospital emergency rooms, urgent care centers, pediatric offices and healthcare providers will benefit -

Novel Epigenomic Approach Provides Proof of Concept for Early Cancer Detection Paving the Way for Next-Generation Screening Tests